This brand name is authorized in Australia, New Zealand
The drug COLOXYL contains one active pharmaceutical ingredient (API):
|
1
Docusate
UNII F05Q2T2JA0 - DOCUSATE SODIUM
|
|
Docusate is an anionic wetting agent, which acts as a faecal softener by lowering the surface tension and allowing penetration of accumulated hard dry faeces by water and salts. Docusate sodium also possesses stimulant activity. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A06AA02 | Docusate sodium | A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AA Softeners, emollients |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 4200C |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 208, 209 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
